Skip to main content

Wave Life Sciences, Inc.

WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001631574

In the last 90 days, Wave Life Sciences, Inc. insiders filed 0 open-market purchases and 4 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.

Q1 2022 vs. Q4 2021

How the institutions holding Wave Life Sciences, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of WVE: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders9082−8
Shares47.3M47.7M+396.1K (+0.8%)
Value$148.5M$95.4M−$53.1M (−35.7%)

New holders (8)

Institutions that held Wave Life Sciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to WVE in Q1 2022
InstitutionSharesValue% of portfolio
FMR LLC66,594$133.0K0.00%
Mirabella Financial Services LLP21,900$44.0K0.01%
Running Point Capital Advisors, LLC10,000$20.0K0.01%
Amalgamated Bank7,218$14.0K0.00%
Amalgamated Financial Corp.7,218$14.0K0.00%
Federated Hermes, Inc.1,101$2.00K0.00%
Aquatic Capital Management LLC1,100$2.00K0.00%
Ellevest, Inc.32$00.00%

Sold out (16)

Institutions that held Wave Life Sciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.